Search results
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
The Motley Fool via AOL· 6 days agoU.S. sales of Humira plummeted by 39.9% year over year in the first quarter to $1.8 billion. Luckily, sales of Rinvoq, an arthritis tablet, and Skyrizi, a psoriasis injection ...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 3 days agoThe company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including ...
Maryland Drug Board Advances Ozempic, Other Cost Reviews (1)
Bloomberg Law· 5 days agoBlockbuster diabetes drugs Ozempic and Trulicity will be included in the Maryland prescription drug board’s first cost review, a monthslong process that will help the panel determine whether ...
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 18 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately 903,885 ...